1. Home
  2. EARN vs ANIK Comparison

EARN vs ANIK Comparison

Compare EARN & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EARN

Ellington Residential Mortgage REIT of Beneficial Interest

HOLD

Current Price

$4.79

Market Cap

172.1M

Sector

Real Estate

ML Signal

HOLD

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

HOLD

Current Price

$14.90

Market Cap

191.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EARN
ANIK
Founded
2012
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
172.1M
191.4M
IPO Year
2012
1996

Fundamental Metrics

Financial Performance
Metric
EARN
ANIK
Price
$4.79
$14.90
Analyst Decision
Buy
Buy
Analyst Count
2
1
Target Price
$5.38
$17.00
AVG Volume (30 Days)
392.7K
110.1K
Earning Date
06-16-2026
04-29-2026
Dividend Yield
20.51%
N/A
EPS Growth
N/A
80.16
EPS
N/A
N/A
Revenue
N/A
$112,819,000.00
Revenue This Year
$7.69
$5.98
Revenue Next Year
$19.57
$7.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.27
$7.90
52 Week High
$6.08
$16.24

Technical Indicators

Market Signals
Indicator
EARN
ANIK
Relative Strength Index (RSI) 59.02 51.88
Support Level $4.54 $13.81
Resistance Level $5.36 $15.01
Average True Range (ATR) 0.09 0.89
MACD 0.02 -0.28
Stochastic Oscillator 92.11 68.87

Price Performance

Historical Comparison
EARN
ANIK

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Share on Social Networks: